PMID- 28623743 OWN - NLM STAT- MEDLINE DCOM- 20180705 LR - 20180705 IS - 1879-1484 (Electronic) IS - 0021-9150 (Linking) VI - 263 DP - 2017 Aug TI - Repeated measurements of serum concentrations of TNF-alpha, interleukin-6 and interleukin-10 in the evaluation of internal carotid artery stenosis progression. PG - 97-103 LID - S0021-9150(17)30257-5 [pii] LID - 10.1016/j.atherosclerosis.2017.06.008 [doi] AB - BACKGROUND AND AIMS: The inflammatory process (with TNFalpha, interleukin-6 and interleukin-10 involvement) plays a key role in the development, progression and destabilization of atherosclerotic plaques. The aim of this study was to assess the importance of double-checked measurements of TNFalpha, interleukin-6 (IL-6) and interleukin-10 (Il-10) serum levels in patients with internal carotid artery (ICA) stenosis to determine the dynamics of changes in the stenosis degree and in the ultrasound plaque morphology. METHODS: The study included 65 patients with ICA stenosis. Ultrasound of the carotid arteries was performed during qualification and every 3 months to identify any progression of stenosis degree and dynamics of changes in plaque morphology. Serum concentrations of TNF-alpha, IL-6 and IL-10 were measured during qualification and at month 6 of the study. Calculations considered cytokine concentrations and their indices determined as relative differences of cytokine levels assessed in the first and in second tests. RESULTS: Patients with increasing degree of ICA stenosis had higher indices of IL-6 and IL-10 than patients without any increase in the stenosis degree. In patients with unfavorable dynamics of changes in plaque morphology, significantly higher levels of interleukin-6 were found in the second test; these patients had higher indices of IL-6 and IL-10 than patients with favorable dynamics of atherosclerotic plaque morphology on ultrasound. CONCLUSIONS: Long-term trends in serum concentrations of IL-6 and IL-10 in patients with ICA stenosis allow to predict the progression of the degree of stenosis and the unfavorable change of atherosclerotic plaque morphology. CI - Copyright (c) 2017 Elsevier B.V. All rights reserved. FAU - Puz, Przemyslaw AU - Puz P AD - Department of Neurology, High School of Science, Medical University of Silesia, Clinical Hospital No 7, Professor Leszek Giec Upper Silesian Medical Centre, Katowice, Poland. Electronic address: ppuz@tlen.pl. FAU - Lasek-Bal, Anetta AU - Lasek-Bal A AD - Department of Neurology, High School of Science, Medical University of Silesia, Clinical Hospital No 7, Professor Leszek Giec Upper Silesian Medical Centre, Katowice, Poland. LA - eng PT - Journal Article DEP - 20170603 PL - Ireland TA - Atherosclerosis JT - Atherosclerosis JID - 0242543 RN - 0 (IL10 protein, human) RN - 0 (IL6 protein, human) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) RN - 130068-27-8 (Interleukin-10) SB - IM MH - Aged MH - Aged, 80 and over MH - Carotid Artery, Internal/*metabolism MH - Carotid Stenosis/*blood/diagnostic imaging MH - Disease Progression MH - Female MH - Humans MH - Interleukin-10/*blood MH - Interleukin-6/*blood MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Prospective Studies MH - Reproducibility of Results MH - Tumor Necrosis Factor-alpha/*blood MH - Ultrasonography OTO - NOTNLM OT - Carotid stenosis OT - Interleukin-10 OT - Interleukin-6 OT - Tumor necrosis factor alpha OT - Unstable carotid plaque EDAT- 2017/06/18 06:00 MHDA- 2018/07/06 06:00 CRDT- 2017/06/18 06:00 PHST- 2017/01/20 00:00 [received] PHST- 2017/05/16 00:00 [revised] PHST- 2017/06/02 00:00 [accepted] PHST- 2017/06/18 06:00 [pubmed] PHST- 2018/07/06 06:00 [medline] PHST- 2017/06/18 06:00 [entrez] AID - S0021-9150(17)30257-5 [pii] AID - 10.1016/j.atherosclerosis.2017.06.008 [doi] PST - ppublish SO - Atherosclerosis. 2017 Aug;263:97-103. doi: 10.1016/j.atherosclerosis.2017.06.008. Epub 2017 Jun 3.